Updates from FDA

APhA Staff

We’ll see soon that digital health is simply health care, said Daniel Zlott, PharmD, APhA’s senior vice president of education and business development, during APhA’s second annual DigitalHealth.Rx summit, chaired by Parisa Vatanka, PharmD, which was held in-person on March 17, 2022, in conjunction with APhA2022 in San Antonio, TX.

Loren Bonner

A meta-analysis of randomized clinical trials published February 2022 in JAMA Psychiatry compared antidepressant monotherapy against combined antidepressant therapy and found superior treatment outcomes were associated with combination therapies.

Clarissa Chan, PharmD

CDC recently approved new pneumococcal vaccine (PCV) recommendations.

Maria G. Tanzi, PharmD

Although pandemic restrictions around the United States are relaxing, CDC is still closely monitoring the SARS-CoV-2 virus Omicron variants, including BA.1, BA.1.1, and especially BA.2 lineages.

Clarissa Chan, PharmD